Filtered By:
Source: Thrombosis Research
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 221 results found since Jan 2013.
Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study
The impact of cancer and other comorbidity on the risk of venous thromboembolism (VTE) after stroke is poorly understood.
Source: Thrombosis Research - September 28, 2016 Category: Hematology Authors: Priscila Corraini, Anne Gulbech Ording, Victor W. Henderson, Szimonetta Sz épligeti, Erzsébet Horváth-Puhó, Henrik Toft Sørensen Tags: Original Article Source Type: research
Endothelial cell senescence and thrombosis: Ageing clots
Age is an important cardiovascular risk factor. Among others, age is associated with an increased risk to develop thrombotic cardiovascular complications, both in the arterial (acute myocardial infarction, stroke) and the venous (deep vein thrombosis, pulmonary embolism) system, which cannot be explained by the age-associated increase in cardiovascular risk factors alone. A number of studies have demonstrated that the accumulation of senescent endothelial cells and specific phenotypic and functional alterations associated with endothelial cell senescence may play an important role during the development and progression of ...
Source: Thrombosis Research - September 18, 2016 Category: Hematology Authors: Magdalena L. Bochenek, Eva Sch ütz, Katrin Schäfer Tags: Review Article Source Type: research
Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study
Platelet count is used to determine bleeding risk and monitoring thrombopoiesis. While abnormal platelet counts are associated with mortality and morbidity, it is unclear whether it also apply to platelet counts within reference range.We investigated the relationship between platelet count (100 –450×109/L) and mortality, development of future cardiovascular disease (myocardial infarction, ischaemic stroke, or peripheral vascular disease), venous thromboembolism, bleeding or cancer in the general population.
Source: Thrombosis Research - August 20, 2016 Category: Hematology Authors: P.J. Vinholt, A.M. Hvas, H. Frederiksen, L. Bathum, M.K. J ørgensen, M. Nybo Source Type: research
Clinical and laboratory predictors of deep vein thrombosis after acute stroke: Does D-dimer really improve predictive power?
We thank Kola and colleagues for their interest in our work titled ‘Clinical and laboratory predictors of deep vein thrombosis after acute stroke’ recently published in Thrombosis Research [1]. We are grateful for their thoughtful comments around the study methodology and data presentation [2].
Source: Thrombosis Research - August 11, 2016 Category: Hematology Authors: Ibrahim O. Balogun, Lara N. Roberts, Roopen Arya Tags: Correspondence Source Type: research
SePARating thrombosis and hemostasis?
Heart attack and ischemic stroke, which commonly arise from thrombotic occlusions, are the world-leading causes of death and a major health burden. In most cases, the rupture or erosion of an unstable atherosclerotic plaque, which results in the exposure of thrombogenic extracellular matrix proteins, triggers arterial thrombosis [14]. Under these conditions, platelets, which circulate in the blood stream, become captured and activated by extracellular matrix proteins. Inevitably, platelet activation leads to thrombus formation at sites of damage via the action of platelet integrins, predominantly αIIbβ3, and the presence...
Source: Thrombosis Research - July 20, 2016 Category: Hematology Authors: David Stegner Tags: Editorial Source Type: research
ABCB1 SNP rs4148738 Modulation of Apixaban Interindividual Variability
Direct Oral AntiCoagulants (DOACs) were approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF), for the prophylaxis of venous thromboembolism (VTE), in elective orthopaedic surgery, for treatment of acute VTE and prevention of recurrencies [1]. Apixaban is an orally active, direct selective factor Xa inhibitor [2,3].
Source: Thrombosis Research - July 11, 2016 Category: Hematology Authors: Claudia Dimatteo, Giovanna D'Andrea, Gennaro Vecchione, Oriana Paoletti, Giovanni Luca Tiscia, Rosa Santacroce, Michele Correale, Natale Brunetti, Elvira Grandone, Sophie Testa, Maurizio Margaglione Source Type: research
ABCB1 SNP rs4148738 modulation of apixaban interindividual variability
Direct Oral AntiCoagulants (DOACs) were approved to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF), for the prophylaxis of venous thromboembolism (VTE), in elective orthopaedic surgery, for treatment of acute VTE and prevention of recurrencies [1]. Apixaban is an orally active, direct selective factor Xa inhibitor [2,3].
Source: Thrombosis Research - July 11, 2016 Category: Hematology Authors: Claudia Dimatteo, Giovanna D'Andrea, Gennaro Vecchione, Oriana Paoletti, Giovanni Luca Tiscia, Rosa Santacroce, Michele Correale, Natale Brunetti, Elvira Grandone, Sophie Testa, Maurizio Margaglione Tags: Correspondence Source Type: research
Clinical and laboratory predictors of deep vein thrombosis after acute stroke; does D-dimer really improve predictive power?
We have read with great interest the paper “Clinical and laboratory predictors of deep vein thrombosis after acute stroke” by Balogun et al. [1], in which the authors investigate the interesting and relevant topic of deep vein thrombosis (DVT) prediction after acute stroke. Specifically, their main research question focusses on the predictive value of stroke severity score and markers of haemostatic activation. This is a relevant question as venous thrombosis, mainly manifested as DVT and pulmonary embolism, is regarded as a serious, potentially life-threatening complication in stroke patients, even though the reports ...
Source: Thrombosis Research - July 3, 2016 Category: Hematology Authors: Vasilis Kola, Hugoline de Haan, Bob Siegerink Tags: Correspondence Source Type: research
Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation
Multiple antithrombotic agents are available for stroke prevention in atrial fibrillation (AF). A decision aid can assist patients in making informed decisions that best serves their needs.
Source: Thrombosis Research - June 14, 2016 Category: Hematology Authors: Safoora Fatima, Anne Holbrook, Sam Schulman, Steve Park, Sue Troyan, Greg Curnew Tags: Full Length Article Source Type: research
Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities Study
Von Willebrand factor (VWF), a large multimeric glycoprotein, plays a critical role in hemostasis. It binds to subendothelial collagen at the site of vascular injury where it facilitates platelet activation. Given the role of VWF in platelet activation, and the role of platelets in cardiovascular events, such as myocardial infarction (MI) and ischemic stroke, VWF may influence the risk of cardiovascular disease (CVD). In addition, evidence suggests that VWF may affect CVD risk by playing a role in atherogenesis by direct participation in plaque formation [1].
Source: Thrombosis Research - May 31, 2016 Category: Hematology Authors: Craig D. Seaman, Kristen M. George, Margaret Ragni, Aaron R. Folsom Source Type: research
Clinical and laboratory predictors of deep vein thrombosis after acute stroke
Deep vein thrombosis (DVT) is a common complication of acute stroke, but the new incidence in the era of improved specialist input in stroke care is yet unknown. The models for VTE diagnosis is well established, but prediction models to target at-risk patients for pharmacological prophylaxis is lacking and requires further research, particularly in the aftermath of acute stroke.
Source: Thrombosis Research - April 8, 2016 Category: Hematology Authors: Ibrahim O. Balogun, Lara N. Roberts, Raj Patel, Rohan Pathansali, Lalit Kalra, Roopen Arya Tags: Full Length Article Source Type: research
